Response to ‘Re: Kakkos Et Al. Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Phase III Trials’
European Journal of Vascular and Endovascular Surgery - United Kingdom
doi 10.1016/j.ejvs.2014.12.007
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2015
Authors
Publisher
Elsevier BV